End of life care in chronic obstructive pulmonary disease: In search of a good death

International Journal of COPD

Volumn 3, Issue 1, 2008, Pages 11-29

  Spathis, Anna ^a   Booth, Sara ^a  

^a CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Advance care planning (MeSH); Chronic obstructive pulmonary disease (MeSH); Dyspnoea (MeSH); Palliative care (MeSH)

Indexed keywords

ALPRAZOLAM; ANALGESIC AGENT; ANXIOLYTIC AGENT; BENZODIAZEPINE DERIVATIVE; BUSPIRONE; CODEINE; DIHYDROCODEINE; IBUPROFEN; MORPHINE; NONSTEROID ANTIINFLAMMATORY AGENT; NORTRIPTYLINE; OPIATE; PARACETAMOL; PAROXETINE; PLACEBO; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRICYCLIC ANTIDEPRESSANT AGENT;

ANXIETY; BEHAVIOR THERAPY; CARBON DIOXIDE TENSION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL TRIAL; CONSTIPATION; DEATH; DEPRESSION; DIZZINESS; DOCTOR PATIENT RELATION; DROWSINESS; DYSPNEA; EVIDENCE BASED PRACTICE; FATIGUE; FEVER; HEALTH CARE DELIVERY; HEALTH CARE PLANNING; HEALTH CARE QUALITY; HEALTH SERVICE; HUMAN; KINESIOTHERAPY; LONG TERM CARE; MEDICAL PRACTICE; NAUSEA; OXYGEN SATURATION; OXYGEN THERAPY; PAIN; PALLIATIVE THERAPY; PROGNOSIS; PULMONARY REHABILITATION; QUALITY OF LIFE; RELAXATION TRAINING; REVIEW; SIDE EFFECT; SYMPTOMATOLOGY; TERMINAL CARE; VOMITING;

HEALTH SERVICES ACCESSIBILITY; HEALTH SERVICES NEEDS AND DEMAND; HUMANS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUALITY OF LIFE; TERMINAL CARE;

EID: 42149098751     PISSN: 11769106     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (187)

1. Abernethy A, Currow D, Frith P, et al. 2005. Prescribing palliative oxygen: a clinician survey of expected benefit and patterns of use. Palliat Med, 19:168-70.
2. Abernethy A, Currow D, Frith P, et al. 2003. Randomised, double blind, placebo controlled crossover trial of sustained release morphine for the management of refractory dyspnoea. BMJ, 327:523-8.
3. Addington-Hall J. 1998. Reaching out: specialist palliative care for adults with non-malignant disease, Occasional Paper 14: London: National Council for Hospices and Specialist Palliative Care Services.
4. Addington-Hall J. 2002. Research sensitivities to palliative care patients. Eur J Cancer Care Engl, 11:220-4.
5. Ahlberg K, Ekman T, Gaston J, et al. 2003. Assessment and management of cancer-related fatigue in adults. Lancet, 362:640-50.
6. Aiken L, Butner J, Lockhart C, et al. 2006. Outcome evaluation of a randomized trial of the PhoenixCare intervention: program of case management and coordinated care for the seriously chronically ill. J Palliat Med, 9:111-26.
7. Argyropoulou P, Patakas D, Koukou A, et al. 1993. Buspirone effect on breathlessness and exercise performance in patients with chronic obstructive pulmonary disease. Respiration, 60:216-20.
8. Au D, Udris E, Fihn S, et al. 2006. Differences in health care utilization at the end of life among patients with chronic obstructive pulmonary disease and patients with lung cancer. Arch Intern Med, 166:326-31.
9. Aydin IO, Ulusahin A. 2001. Depression, anxiety comorbidity, and disability in tuberculosis and chronic obstructive pulmonary disease patients: applicability of GHQ-12.
10. Back A, Arnold R, Quill T. 2003. Hope for the best, and prepare for the worst. Ann Intern Med, 138:439-43.
11. Bailey P. 2004. The dyspnea-anxiety-dyspnea cycle: COPD patients' stories of breathlessness. Qual Health Res, 14:760-78.
12. Barnes K, Jones L, Tookman A, et al. 2007. Acceptability of an advance care planning interview schedule: a focus group study. Palliat Med, 21:23-8.
13. Belman MJ, Botnick WC, Shin JW. 1996. Inhaled bronchodilators reduce dynamic hyperinflation during exercise in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med, 153:967-75.
14. Blackler L, Mooney C, Jones C. 2004. Palliative care in the management of chronic obstructive pulmonary disease. Br J Nurs, 13:518-21.
15. Booth S, Farquhar M, Gysels M, et al. 2006. The impact of a breathlessness intervention service BIS on the lives of patients with intractable dyspnea: a qualitative phase 1 study. Palliat Support Care, 4:287-93.
16. Booth S, Kelly MJ, Cox NP, et al. 1996. Does oxygen help dyspnea in patients with cancer? Am J Respir Crit Care Med, 153:1515-8.
17. Booth S, Wade R, Johnson M, et al. 2004. The use of oxygen in the palliation of breathlessness A report of the expert working group of the Scientific Committee of the Association of Palliative Medicine. Respir Med, 98:66-77.
18. Borson S, McDonald GJ, Gayle T, et al. 1992. Improvement in mood, physical symptoms, and function with nortriptyline for depression in patients with chronic obstructive pulmonary disease.
19. Braun U, Beyth R, Ford M, et al. 2007. Defining limits in care of terminally ill patients. BMJ, 334:239-41.
20. Brenes G. 2003. Anxiety and chronic obstructive pulmonary disease: prevalence, impact, and treatment. Psychosom Med, 65:963-70.
21. Breslin EH. 1992. The pattern of respiratory muscle recruitment during pursed-lip breathing. Chest, 101:75-8.
22. Brown ML, Carrieri V, Janson B, et al. 1986. Lung cancer and dyspnea: the patient's perception. Oncol Nurs Forum, 13:19-24.
23. Bruera E, Schoeller T, MacEachern T. 1992. Symptomatic benefit of supplemental oxygen in hypoxemic patients with terminal cancer: the use of the N of 1 randomized controlled trial. J Pain Symptom Manage, 7:365-8.
24. Bruera E, Valero V, Driver L, et al. 2006. Patient-controlled methylphenidate for cancer fatigue: a double-blind, randomized, placebo-controlled trial. J Clin Oncol, 24:2073-8.
25. Brumley R. 2002. Future of end-of-life care: the managed care organization perspective. J Palliat Med, 5:263-70.
26. Byock I, Twohig J, Merriman M, et al. 2006. Promoting excellence in end-of-life care: a report on innovative models of palliative care. J Palliat Med, 9:137-51.
27. Carrieri VK, Janson B. 1986. Strategies patients use to manage the sensation of dyspnea. West J Nurs Res, 8:284-305.
28. Carrieri-Kohlman V. 2006. Non-pharmacological approaches. In: Booth S, Dudgeon D. eds. Dyspnoea in Advanced Disease. Oxford: Oxford University Press. p 171-203.
29. Carrieri-Kohlman V, Stulbarg MS. 2002. Dyspnea: assessment and management. In: Hodgkin JE, Celli B, Connors G. eds. Pulmonary Rehabilitation. New York: Lippincot Williams and Wilkins. p 57-90.
30. Chan J, Treece P, Engelberg R, et al. 2004. Narcotic and benzodiazepine use after withdrawal of life support: association with time to death? Chest, 126:286-93.
31. Claessens MT, Lynn J, Zhong Z, et al. 2000. Dying with lung cancer or chronic obstructive pulmonary disease: insights from SUPPORT Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments. J Am Geriatr Soc, 48:S146-53.
32. Coventry P, Grande G, Richards D, et al. 2005. Prediction of appropriate timing of palliative care for older adults with non-malignant life-threatening disease: a systematic review. Age Ageing, 34:218-27.
33. Croft M. 2005. Palliative care in end-stage COPD. Br J Gen Pract, 55:234.
34. Currow DC, Abernethy AP, Peter F. 2003. Morphine for the management of refractory dyspnoea: authors' reply. BMJ, 327:1288-1289.
35. Curtis J, Engelberg R, Wenrich M, et al. 2005. Communication about palliative care for patients with chronic obstructive pulmonary disease. J Palliat Care, 21:157-64.
36. Curtis J, Wenrich M, Carline J, et al. 2002. Patients' perspectives on physician skill in end-of-life care: differences between patients with COPD, cancer, and AIDS. Chest, 122:356-62.
37. Curtis JR, Engelberg RA, Nielsen EL, et al. 2004. Patient-physician communication about end-of-life care for patients with severe COPD. Eur Respir J, 24:200-5.
38. Curtis JR, Patrick DL, Caldwell ES, et al. 2000. Why don't patients and physicians talk about end-of-life care? Barriers to communication for patients with acquired immunodeficiency syndrome and their primary care clinicians. Arch Intern Med, 160:1690-6.
39. Dahlén I, Janson C. 2002. Anxiety and depression are related to the outcome of emergency treatment in patients with obstructive pulmonary disease. Chest, 122:1633-7.
40. Davison S, Simpson C. 2006. Hope and advance care planning in patients with end stage renal disease: qualitative interview study. BMJ, 333:886-889.
41. Department of Health. 2007. Operating framework 2007/8: PCT baseline review of services for end of life care, Department of Health.
42. Ditto PH, Danks JH, Smucker WD, et al. 2001. Advance directives as acts of communication: a randomized controlled trial. Arch Intern Med, 161:421-30.
43. Domingo-Salvany A, Lamarca R, Ferrer M, et al. 2002. Health-related quality of life and mortality in male patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med, 166:680-5.
44. Dy S, Lynn J. 2007. Getting services right for those sick enough to die. BMJ, 334:511-3.
45. Eaton T, Fergusson W, Kolbe J, et al. 2006. Short-burst oxygen therapy for COPD patients: a 6-month randomised, controlled study. Eur Respir J, 27:697-704.
46. Eaton T, Garrett JE, Young P, et al. 2002. Ambulatory oxygen improves quality of life of COPD patients: a randomised controlled study. Eur Respir J, 20:306-12.
47. Eaton T, Lewis C, Young P, et al. 2004. Long-term oxygen therapy improves health-related quality of life. Respir Med, 98:285-93.
48. Edes T, Lindbloom E, Deal J, et al. 2006. Improving care at lower cost for end-stage heart and lung disease: integrating end of life planning with home care. Mo Med, 103:146-51.
49. Edmonds P, Karlsen S, Khan S, et al. 2001. A comparison of the palliative care needs of patients dying from chronic respiratory diseases and lung cancer. Palliat Med, 15:287-95.
50. Eiser N, Harte R, Spiros K, et al. 2005. Effect of treating depression on quality-of-life and exercise tolerance in severe COPD. COPD, 2:233-41.
51. Elkington H, White P. 2002. Chronic obstructive pulmonary disease and primary care. Br J Gen Pract, 52:532-4.
52. Elkington H, White P, Addington-Hall J, et al. 2005. The healthcare needs of chronic obstructive pulmonary disease patients in the last year of life. Palliat Med, 19:485-91.
53. Elkington H, White P, Addington-Hall J, et al. 2004. The last year of life of COPD: a qualitative study of symptoms and services. Respir Med, 98:439-45.
54. Elkington H, White P, Higgs R, et al. 2001. GPs' views of discussions of prognosis in severe COPD. Fam Pract, 18:440-4.
55. Ellershaw J, Ward C. 2003. Care of the dying patient: the last hours or days of life. BMJ, 326:30-34.
56. Elofsson L, Carling, Ohlén J. 2004. Meanings of being old and living with chronic obstructive pulmonary disease. Palliat Med, 18:611-8.
57. Estfan B, Mahmoud F, Shaheen P, et al. 2007. Respiratory function during parenteral opioid titration for cancer pain. Palliat Med, 21:81-6.
58. Felker B, Katon W, Hedrick SC, et al. 2001. The association between depressive symptoms and health status in patients with chronic pulmonary disease.
59. Field M, Cassel K. eds. 1997. Approaching death: improving care at the end of life. Washington: Institute of Medicine.
60. Fox E, Landrum M, Zhong Z, et al. 1999. Evaluation of prognostic criteria for determining hospice eligibility in patients with advanced lung, heart, or liver disease SUPPORT Investigators Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments. JAMA, 282:1638-45.
61. Freeman D, Price D. 2006. ABC of chronic obstructive pulmonary disease Primary care and palliative care. BMJ, 333:188-90.
62. Fried T, Bradley E, Towle V, et al. 2002. Understanding the treatment preferences of seriously ill patients. N Engl J Med, 346:1061-6.
63. Gallo-Silver L, Pollack B. 2000. Behavioral interventions for lung cancer-related breathlessness. Cancer Pract, 8:268-73.
64. George R, Regnard C. 2007. Lethal opioids or dangerous prescribers? Palliat Med, 21:77-80.
65. Gift AG, Cahill CA. 1990. Psychophysiologic aspects of dyspnea in chronic obstructive pulmonary disease: a pilot study. Heart Lung, 19:252-7.
66. Gift AG, Moore T, Soeken K. 1992. Relaxation to reduce dyspnea and anxiety in COPD patients. Nurs Res, 41:242-6.
67. Glare PA, Virik K. 2001. Can we do better in end-of-life care? The mixed management model and palliative care. Med J Aust, 175:530-3.
68. Goodman MD, Tarnoff M, Slotman GJ. 1998. Effect of advance directives on the management of elderly critically ill patients. Crit Care Med, 26:701-4.
69. Gore JM, Brophy CJ, Greenstone MA. 2000. How well do we care for patients with end stage chronic obstructive pulmonary disease COPD? A comparison of palliative care and quality of life in COPD and lung cancer. Thorax, 55:1000-6.
70. Gudmundsson G, Gislason T, Janson C, et al. 2005. Risk factors for rehospitalisation in COPD: role of health status, anxiety and depression. Eur Respir J, 26:414-9.
71. Guthrie SJ, Hill KM, Muers ME. 2001. Living with severe COPD: a qualitative exploration of the experience of patients in Leeds. Respir Med, 95:196-204.
72. Hallenbeck J. 2006. Palliative care training for the generalist a luxury or a necessity? J Gen Intern Med, 21:1005-6.
73. Hansen-Flaschen J. 2004. Chronic obstructive pulmonary disease: the last year of life. Respir Care, 49:90-7.
74. Healthcare Commission. 2006. Clearing the air: a national study of chronic obstructive pulmonary disease, Commission for Healthcare Audit and Inspection.
75. Healthcare Commission. 2007. Spotlight on complaints: a report on second stage complaints about the NHS in England, Commission for Healthcare, Audit and Inspection.
76. Heaven CM, Maguire P. 1997. Disclosure of concerns by hospice patients and their identification by nurses. Palliat Med, 11:283-90.
77. Heffner JE, Fahy B, Hilling L, et al. 1996. Attitudes regarding advance directives among patients in pulmonary rehabilitation. Am J Respir Crit Care Med, 154:1735-40.
78. Hermiz O, Comino E, Marks G, et al. 2002. Randomised controlled trial of home based care of patients with chronic obstructive pulmonary disease. BMJ, 325:938.
79. Hill KM, Muers MF. 2000. Palliative care for patients with non-malignant end stage respiratory disease. Thorax, 55:979-81.
80. Jennings AL, Davies AN, Higgins JPT, et al. 2002. A systematic review of the use of opioids in the management of dyspnoea. Thorax, 57:939-44.
81. Jones I, Kirby A, Ormiston P, et al. 2004. The needs of patients dying of chronic obstructive pulmonary disease in the community. Fam Pract, 21:310-3.
82. Katsura H, Yamada K, Wakabayashi R, et al. 2005. The impact of dyspnoea and leg fatigue during exercise on health- related quality of life in patients with COPD. Respirology, 10:485-90.
83. Kendall M, Harris F, Boyd K, et al. 2007. Key challenges and ways forward in researching the good death: qualitative in-depth interview and focus group study. BMJ, 334:521.
84. King N, Thomas K, Martin N, et al. 2005. 'Now nobody falls through the net': practitioners' perspectives on the Gold Standards Framework for community palliative care. Palliat Med, 19:619-27.
85. Knauft E, Nielsen E, Engelberg R, et al. 2005. Barriers and facilitators to end-of-life care communication for patients with COPD. Chest, 127:2188-96.
86. Konstan MW, Byard PJ, Hoppel CL, et al. 1995. Effect of high-dose ibuprofen in patients with cystic fibrosis. N Engl J Med, 332:848-54.
87. Kunik M, Roundy K, Veazey C, et al. 2005. Surprisingly high prevalence of anxiety and depression in chronic breathing disorders. Chest, 127:1205-11.
88. Kunik ME, Braun U, Stanley MA, et al. 2001. One session cognitive behavioural therapy for elderly patients with chronic obstructive pulmonary disease. Psychol Med, 31:717-23.
89. Lacasse Y, Beaudoin L, Rousseau L, et al. 2004. Randomized trial of paroxetine in end-stage COPD. Monaldi Arch Chest Dis, 61:140-7. Lacasse Y, Goldstein R, Lasserson TJ, et al. 2006. Pulmonary rehabilitation for chronic obstructive pulmonary disease. Cochrane Database Syst Rev, CD003793.
90. Lawton J. 2001. Gaining and maintaining consent: ethical concerns raised in a study of dying patients. Qual Health Res, 11:693-705.
91. Leach R. 2005. Palliative medicine and non-malignant, end-stage respiratory disease. In: Doyle D, Hanks G, Cherny N, Calman K. eds. Oxford Textbook of Palliative Medicine. Oxford: Oxford University Press. p 894-916.
92. Lehman R. 2004. How long can I go on like this? Dying from cardiorespiratory disease. Br J Gen Pract, 54:892-3.
93. Lesko S, M. 2003. The safety of ibuprofen suspension in children. Int J Clin Pract Suppl:50-3.
94. Lesko S, M., Louik C, Vezina R, M., et al. 2002. Asthma morbidity after the short-term use of ibuprofen in children. Pediatrics, 109:E20.
95. Lewis CA, Eaton TE, Young P, et al. 2003. Short-burst oxygen immediately before and after exercise is ineffective in nonhypoxic COPD patients. Eur Respir J, 22:584-8.
96. Lisansky DP, Clough DH. 1996. A cognitive-behavioral self-help educational program for patients with COPD: a pilot study. Psychother Psychosom, 65:97-101.
97. Liss HP, Grant BJ. 1988. The effect of nasal flow on breathlessness in patients with chronic obstructive pulmonary disease. Am Rev Respir Dis, 137:1285-8.
98. Luchette FA, Radafshar SM, Kaiser R, et al. 1994. Prospective evaluation of epidural versus intrapleural catheters for analgesia in chest wall trauma.
99. Lunney J, Lynn J, Foley D, et al. 2003. Patterns of functional decline at the end of life. JAMA, 289:2387-92.
100. Lynn J, Ely EW, Zhong Z, et al. 2000. Living and dying with chronic obstructive pulmonary disease. J Am Geriatr Soc, 48:S91-100.
101. Lynn J, Goldstein N. 2003. Advance care planning for fatal chronic illness: avoiding commonplace errors and unwarranted suffering. Ann Intern Med, 138:812-8.
102. Lynn J, Teno JM, Phillips RS, et al. 1997. Perceptions by family members of the dying experience of older and seriously ill patients SUPPORT Investigators Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments. Ann Intern Med, 126:97-106.
103. Madsen SM, Mirza MR, Holm S, et al. 2002. Attitudes towards clinical research amongst participants and nonparticipants. J Intern Med, 251:156-68.
104. Man G, Hsu K, Sproule B. 1986. Effect of alprazolam on exercise and dyspnea in patients with chronic obstructive pulmonary disease. Chest, 90:832-836.
105. Mashford M, Aranda S, Ashby M, et al. 2001. Therapeutic guidelines in palliative care. North Melbourne, Australia: Therapeutic Guidelines Limited.
106. Mazzocato C, Buclin T, Rapin CH. 1999. The effects of morphine on dyspnea and ventilatory function in elderly patients with advanced cancer: a randomized double-blind controlled trial. Ann Oncol, 10:1511-4.
107. McDonald CF, Blyth CM, Lazarus MD, et al. 1995. Exertional oxygen of limited benefit in patients with chronic obstructive pulmonary disease and mild hypoxemia. Am J Respir Crit Care Med, 152:1616-9.
108. McKeever TM, Lewis SA, Smit HA, et al. 2005. The association of acetaminophen, aspirin, and ibuprofen with respiratory disease and lung function. American journal of respiratory and critical care medicine, 171:966-71.
109. McKinley R, Stokes T, Exley C, et al. 2004. Care of people dying with malignant and cardiorespiratory disease in general practice. Br J Gen Pract, 54:909-13.
110. Middlewood S, Gardner G, Gardner A. 2001. Dying in hospital: medical failure or natural outcome? J Pain Symptom Manage, 22:1035-41.
111. MRC Working Party. 1981. Long term domiciliary oxygen therapy in chronic hypoxic cor pulmonale complicating chronic bronchitis and emphysema. Lancet, 1:681-686.
112. Mulligan J. 2006. Who will champion COPD patients? Nurs Times, 102:45.
113. Munday D, Dale J. 2007. Palliative care in the community. BMJ, 334:809-10.
114. Murray S, Kendall M, Boyd K, et al. 2005. Illness trajectories and palliative care. BMJ, 330:1007-11.
115. Nandi K, Smith AA, Crawford A, et al. 2003. Oxygen supplementation before or after submaximal exercise in patients with chronic obstructive pulmonary disease. Thorax, 58:670-3.
116. National Institute of Clinical Excellence. 2004. Chronic obstructive pulmonary disease. Thorax, 59:1-232.
117. NCCN. 2005. Cancer-related fatigue: clinical practice guidelines in oncology, National Comprehensive Cancer Network.
118. NCPC. 2006. Minimum dataset report 2005/6, National Council for Palliative Care.
119. NHS. 2006. End of life care programme: a progress report [online]. URL: http://www.endoflifecare.nhs.uk.
120. NHS Executive. 1996. A policy framework for commissioning cancer services: palliative care services, EL(96)85: NHS Executive.
121. NIH. 2003. Data Fact Sheet: Chronic Obstructive Pulmonary Disease, 30-5229: National Heart, Blood and Lung Institute.
122. NIH. 2004. National Institutes of Health State-of-the-Science Conference Statement on Improving End-of-Life Care. NIH Consensus Development Program.
123. Nishimura K, Izumi T, Tsukino M, et al. 2002. Dyspnea is a better predictor of 5-year survival than airway obstruction in patients with COPD. Chest, 121:1434-40.
124. Nonoyama M, Brooks D, Guyatt G, et al. 2007. Effect of Oxygen on Health Quality of Life in COPD Patients with Transient Exertional Hypoxemia. Am J Respir Crit Care Med.
125. Norwood R. 2006. Prevalence and impact of depression in chronic obstructive pulmonary disease patients. Curr Opin Pulm Med, 12:113-7.
126. NOTT group. 1980. Continuous or nocturnal oxygen therapy in hypoxaemic chronic obstructive lung disease: a clinical trial. Ann Intern Med, 93:391-398.
127. O'Donnell D, Aaron S, Bourbeau J, et al. 2003. Canadian Thoracic Society recommendations for management of chronic obstructive pulmonary disease - 2003. Can Respir J, 10:11A-65A.
128. O'Donnell DE, Revill SM, Webb KA. 2001. Dynamic hyperinflation and exercise intolerance in chronic obstructive pulmonary disease. Am J Respir Crit Care Med, 164:770-7.
129. Pang SC, Tse C, Chan K, et al. 2004. An empirical analysis of the decision-making of limiting life- sustaining treatment for patients with advanced chronic obstructive pulmonary disease in Hong Kong, China. J Crit Care, 19:135-44.
130. Papp LA, Weiss JR, Greenberg HE, et al. 1995. Sertraline for chronic obstructive pulmonary disease and comorbid anxiety and mood disorders.
131. Paz D, de Montes O, López J, et al. 2007. Pulmonary rehabilitation improves depression, anxiety, dyspnea and health status in patients with COPD. Am J Phys Med Rehabil, 86:30-6.
132. Pfeifer M, Mitchell C, Chamberlain L. 2003. The value of disease severity in predicting patient readiness to address end-of-life issues. Arch Intern Med, 163:609-12.
133. Poole PJ, Chase B, Frankel A, et al. 2001. Case management may reduce length of hospital stay in patients with recurrent admissions for chronic obstructive pulmonary disease. Respirology, 6:37-42.
134. Rammohan KW, Rosenberg JH, Lynn DJ, et al. 2002. Efficacy and safety of modafinil Provigil for the treatment of fatigue in multiple sclerosis: a two centre phase 2 study. J Neurol Neurosurg Psychiatr, 72:179-83.
135. Ream E, Richardson A. 1997. Fatigue in patients with cancer and chronic obstructive airways disease: a phenomenological enquiry. Int J Nurs Stud, 34:44-53.
136. Reishtein J. 2005. Relationship between symptoms and functional performance in COPD. Res Nurs Health, 28:39-47.
137. Renfroe KL. 1988. Effect of progressive relaxation on dyspnea and state anxiety in patients with chronic obstructive pulmonary disease.
138. Robinson T. 2005. Living with severe hypoxic COPD: the patients' experience. Nurs Times, 101:38-42.
139. Schwartzstein RM, Lahive K, Pope A, et al. 1987. Cold facial stimulation reduces breathlessness induced in nominal subjects. Am Rev Respir Dis, 136:58-61.
140. Schwartzstein RM, Simon PM, Weiss JW, et al. 1989. Breathlessness induced by dissociation between ventilation and chemical drive. Am Rev Respir Dis, 139:1231-7.
141. Seamark DA, Blake SD, Seamark CJ, et al. 2004. Living with severe chronic obstructive pulmonary disease COPD: perceptions of patients and their carers An interpretative phenomenological analysis. Palliat Med, 18:619-25.
142. Selecky P, Eliasson C, Hall R, et al. 2005. Palliative and end-of-life care for patients with cardiopulmonary diseases: American College of Chest Physicians position statement. Chest, 128:3599-610.
143. Shah S. 2005. The Liverpool Care Pathway: its impact on improving the care of the dying. Age Ageing, 34:197-8.
144. Shaheen SO, Newson RB, Sherriff A, et al. 2002. Paracetamol use in pregnancy and wheezing in early childhood. Thorax, 57:958-63.
145. Shaheen SO, Sterne JA, Songhurst CE, et al. 2000. Frequent paracetamol use and asthma in adults. Thorax, 55:266-70.
146. Shuttleworth A. 2005. Palliative care for people with end-stage non-malignant lung disease. Nurs Times, 101:48-9.
147. Simpson DE. 2000. Introduction to the National Consensus Conference on Medical Education for Care Near the End of Life: executive summary. J Palliat Med, 3:87-92.
148. Simpson DE, Rehm J, Biernat K, et al. 1999. Advancing educational scholarship through the End of Life Physician Education Resource Center EPERC. J Palliat Med, 2:421-4.
149. Singh NP, Despars JA, Stansbury DW, et al. 1993. Effects of buspirone on anxiety levels and exercise tolerance in patients with chronic airflow obstruction and mild anxiety. Chest, 103:800-4.
150. Skilbeck J, Mott L, Page H, et al. 1998. Palliative care in chronic obstructive airways disease: a needs assessment. Palliat Med, 12:245-54.
151. Skwarska E, Cohen G, Skwarski KM, et al. 2000. Randomized controlled trial of supported discharge in patients with exacerbations of chronic obstructive pulmonary disease. Thorax, 55:907-12.
152. Small S, Lamb M. 1999. Fatigue in chronic illness: the experience of individuals with chronic obstructive pulmonary disease and with asthma. J Adv Nurs, 30:469-78.
153. Smoller JW, Pollack MH, Systrom D, et al. 1998. Sertraline effects on dyspnea in patients with obstructive airways disease.
154. Smucker WD, Ditto PH, Moore KA, et al. 1993. Elderly outpatients respond favorably to a physician-initiated advance directive discussion. J Am Board Fam Pract, 6:473-82.
155. Solano J, Gomes B, Higginson I. 2006. A comparison of symptom prevalence in far advanced cancer, AIDS, heart disease, chronic obstructive pulmonary disease and renal disease. J Pain Symptom Manage, 31:58-69.
156. Somfay A, Porszasz J, Lee SM, et al. 2001. Dose-response effect of oxygen on hyperinflation and exercise endurance in nonhypoxaemic COPD patients. Eur Respir J, 18:77-84.
157. Spathis A, Wade R, Booth S. 2006. Oxygen in the palliation of breathlessness. In: Booth S, Dudgeon D. eds. Dyspnoea in advanced disease. Oxford: Oxford University Press.
158. Stapleton R, Nielsen E, Engelberg R, et al. 2005. Association of depression and life-sustaining treatment preferences in patients with COPD. Chest, 127:328-334.
159. Steinhauser KE, Christakis NA, Clipp EC, et al. 2000a. Factors considered important at the end of life by patients, family, physicians, and other care providers. JAMA, 284:2476-82.
160. Steinhauser KE, Clipp EC, McNeilly M, et al. 2000b. In search of a good death: observations of patients, families, and providers. Ann Intern Med, 132:825-32.
161. Stevenson NJ, Calverley PMA. 2004. Effect of oxygen on recovery from maximal exercise in patients with chronic obstructive pulmonary disease. Thorax, 59:668-72.
162. Sullivan A, Lakoma M, Block S. 2003. The status of medical education in end-of-life care: a national report. J Gen Intern Med, 18:685-95.
163. Sullivan KE, Hébert PC, Logan J, et al. 1996. What do physicians tell patients with end-stage COPD about intubation and mechanical ventilation? Chest, 109:258-64.
164. Sulmasy DP, Lynn J. 1997. End-of-life care. JAMA, 277:1854-1855.
165. Swinburn CR, Wakefield JM, Jones PW. 1984. Relationship between ventilation and breathlessness during exercise in chronic obstructive airways disease is not altered by prevention of hypoxaemia. Clin Sci, 67:515-9.
166. Teno JM, Licks S, Lynn J, et al. 1997. Do advance directives provide instructions that direct care? SUPPORT Investigators Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatment. J Am Geriatr Soc, 45:508-512.
167. Theander K, Unosson M. 2004. Fatigue in patients with chronic obstructive pulmonary disease. J Adv Nurs, 45:172-7.
168. Thomas K, Noble B. 2007. Improving the delivery of palliative care in general practice: an evaluation of the first phase of the Gold Standards Framework. Palliat Med, 21:49-53.
169. Tiep BL, Burns M, Kao D, et al. 1986. Pursed lips breathing training using ear oximetry. Chest, 90:218-21.
170. Tierney WM, Dexter PR, Gramelspacher GP, et al. 2001. The effect of discussions about advance directives on patients' satisfaction with primary care. J Gen Intern Med, 16:32-40.
171. Tonelli MR. 1996. Pulling the plug on living wills A critical analysis of advance directives. Chest, 110:816-22.
172. Traue DC, Ross JR. 2005. Palliative care in non-malignant diseases. J R Soc Med, 98:503-6.
173. Twycross R, Wilcock A, Thorp S. 1999. Palliative Care Formulary. Abingdon: Radcliffe Medical Press.
174. Uhlmann RF, Pearlman RA. 1991. Perceived quality of life and preferences for life-sustaining treatment in older adults. Arch Intern Med, 151:495-7.
175. Uronis HE, Currow DC, Abernethy AP. 2006. Palliative management of refractory dyspnoea in COPD. Int J COPD, 1:289-304.
176. Varkey B. 2006. Unfulfilled palliative care needs of chronic obstructive pulmonary disease patients. Curr Opin Pulm Med, 12:103-5.
177. Veerbeek L, van Zuylen L, Gambles M, et al. 2006. Audit of the Liverpool Care Pathway for the Dying Patient in a Dutch cancer hospital. J Palliat Care, 22:305-308.
178. Vogelzang NJ, Breitbart W, Cella D, et al. 1997. Patient, caregiver, and oncologist perceptions of cancer-related fatigue: results of a tripart assessment survey The Fatigue Coalition. Semin Hematol, 34:4-12.
179. Walker L. 2004. Hypnotherapeutic insights and interventions: a cancer odyssey. Contemp Hypnosis, 21:35-45.
180. Waterhouse JC, Howard P. 1983. Breathlessness and portable oxygen in chronic obstructive airways disease. Thorax, 38:302-6.
181. Wee B, Hillier R, Coles C, et al. 2001. Palliative care: a suitable setting for undergraduate interprofessional education. Palliat Med, 15:487-92.
182. WHO. 1996. Cancer Pain Relief. Geneva: World Health Organisation.
183. WHO. 2003. World Health Report, World Health Organisation, Geneva. URL: http://who.int/whr/2003/en/.
184. Wilson KA, Dowling AJ, Abdolell M, et al. 2000. Perception of quality of life by patients, partners and treating physicians. Qual Life Res, 9:1041-52.
185. Woo K. 2000. Physical activity as a mediator between dyspnea and fatigue in patients with chronic obstructive pulmonary disease. Can J Nurs Res, 32:85-98.
186. Yohannes A, Baldwin RC, Connolly MJ. 2006. Depression and anxiety in elderly patients with chronic obstructive pulmonary disease. Age Ageing, 35:457-9.
187. Yohannes AM, Baldwin RC, Connolly MJ. 2000. Depression and anxiety in elderly outpatients with chronic obstructive pulmonary disease: prevalence, and validation of the BASDEC screening questionnaire. Int J Geriatr Psychiatry, 15:1090-6.